chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 12/31/2021 and 1/31/2021. Patient recently diagnosed with COVID on 9/20/2021 and hospitalized at a different facility from 9/20/2021 to 9/22/2021. Patient presented to emergency department for shortness of breath and required oxygen supplementation 4-5L nasal cannula. Patient received cholecalciferol, ceftriaxone, and dexamethasone. Patients respiratory status continued to deteriorate and patient declined intubation. Patient expired 10/3/2021 at 0917.
I've gotten sicker than a dog; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age vaccination was not reported. The patient received Influenza vaccine Quadrivalent unspecified season and experienced sick. The age group was not reported but taken as adult as per vaccie indication. The patient stated that vaccine comes out I'm not going to get it because every time I've got the flu shot I've got sicker than a dog so why would  take the chance of getting a brand-spanking-new vaccine that's been rushed out. The information regarding consent to follow up was not reported.
Patient states she is not able to move her arm due to pain. Saw her primary health care and was told to take Ibuprofen for pain and apply warm compress. If pain does not subside by Monday patient is advised to get an ultrasound.
Seizure 2 days after 2 month shots.  Mother states no fever due to tylenol administration.  Saw PCP; then neurologist.   Admitted to hospital for one day for EEG.  Order written by MD for Pediatric DT only in the future.
Ear pain and ear ringing started the day after the shot, lasted the weekend (Sat/Sun) and went away for the most part during the week. However it returned 5/8-5/10. I also have a fever of 99.8 this past weekend. I don't know if I had a fever previously because I didn't check.
Severe headache, then about half hour later shortness of breath, the shortness of breath left after a couple of days but my headaches were off and on till I miscarried a couple weeks later, I called my obgyn they told me to call the regular doctor I see, then they told me they couldn't do anything to call where I recieved the vaccine so I tried to call the health dept. that same day up until they closed and their line stayed busy so I finally gave up and took Tylenol, when I started spotting on Nov. 21, 2009 and was took to the E.R. I even told them about my reaction but got no response thats the night I found out of a threatened miscarriage and was put on bedrest.   12/30/09:  Obstetrical records received for date of service 11/02/09 to 12/9/09. Dx:  Missed abortion.  Gravida 4, Para 3, EDC 6/15/10 experienced a missed abortion at 11 weeks EGA, no fetal heart tones were noted on OB US.  Underwent a D & C.  Also c/o SOB at rest after H1N1 vaccine, worse with exertion.
pt had full series of HepB vax, needle stick, titered & found neg, 2 booster vax given. 1-2 mon p 2nd booster exp generalized arthralgias and whole body was stiff; sx tx with apap
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to an unspecified number of patients of unknown age and gender. Medical history and drug reactions were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PROQUAD (lot# L007230, expiration date 03-SEP-2016, dose, frequency and route of administration were not reported). Concomitant medication was not provided. No adverse effects were reported. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Seen by doctor on 06/14/2002,T 97.8 AP 101/61, Intense localized achy left upper arm SQ injection site over the last 24 hours. otherwise fine
Approximately 6 weeks after receiving a Covid booster, ringing of the ears was noticed and has not changed in the course of the past 12 months.
Legionnaire's disease; Mobility decreased; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA LEGIONELLA (Legionnaire's disease) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included INFLUENZA VACCINE (FLU VACCINE VII) for an unknown indication.   On 26-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. On an unknown date, the patient experienced PNEUMONIA LEGIONELLA (Legionnaire's disease) (seriousness criterion medically significant), MOBILITY DECREASED (Mobility decreased) and PYREXIA (Fever). At the time of the report, PNEUMONIA LEGIONELLA (Legionnaire's disease), MOBILITY DECREASED (Mobility decreased) and PYREXIA (Fever) outcome was unknown.            No concomitant medication provided. No treatment information mentioned.  Patient experienced legionnaires disease. Took COVID vaccine and flu vaccine on the same day and could not move. Got a fever as well.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in  Company comment: This spontaneous case concerns a 48 year old female patient with concurrent condition of rheumatoid arthritis, who experienced the unexpected serious (medically significant) event of Pneumonia legionella, unknown days after receiving the second dose of mRNA-1273 vaccine in the COVID-19 vaccination series. The patient received the first dose with the same vaccine about a month ago with no reported adverse events. No information on exact date of the event, detailed clinical course, relevant investigations, treatment and outcome of the event was available in the report. Co-suspect adalimumab could be a risk factor for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case concerns a 48 year old female patient with concurrent condition of rheumatoid arthritis, who experienced the unexpected serious (medically significant) event of Pneumonia legionella, unknown days after receiving the second dose of mRNA-1273 vaccine in the COVID-19 vaccination series. The patient received the first dose with the same vaccine about a month ago with no reported adverse events. No information on exact date of the event, detailed clinical course, relevant investigations, treatment and outcome of the event was available in the report. Co-suspect adalimumab could be a risk factor for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Approximately 15-20 mins following covid J&J vaccine, patient endorsed symptoms of chest tightness and shortness of breath. Patient said she had similar symptoms with past covid vaccine, which at the time she was given Benadryl. About 4 days following her last covid vaccine, she presented to ED with symptoms of shortness of breath.  patient was given 25 mg PO of Benadryl. Following administration, patient reported worsening chest pain.  her vital signs were stable 126/85 pulse 104, O2 99. On exam lungs were CTAB, heart sounds were normal regular rhythm no murmurs no gallops.   Given worsening symptoms, 911 was called and patient was transported to ED for further work up and management.
39 Weeks and 1 day pregnant, estimated due date May 20, 2021. One previous successful pregnancy. Reaction to first shot, sore arm. Reaction to second shot: Vomiting, fever (99.9), lethargy, throbbing joints, headache, tinnitus, 36 hours of nausea, tiredness, sore arm and sweating.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. The patients' current conditions, medical history and concomitant medications were not reported. On unspecified dates, the patients were vaccinated with improperly stored GARDASIL 9 lot # M042853, expiration date 17-JUL-2019 (strength, dose and route of administration were not reported) for prophylaxis. The vaccine was exposed to 32 degree fahrenheit to 35 degree fahrenheit for 480 hours and 10 minutes (incorrect product storage). There was no previous temperature excursion. Digital data logger was involved. No adverse effects were reported. There was no product quality complaint (PQC) involved. This is one of the several reports received from same reporter.; Sender's Comments: US-009507513-1708USA004187: US-009507513-1708USA004188: US-009507513-1708USA004189:
A rash on my stomach that is blotchy, itchy and swollen.  Size 1 in x 1 in.
After getting the vaccination the patient claimed to have a slight fever and body ache. A day later she developed a rash on stomach, lower back, both arms and inside of thigh from knee up
Mild headache/fatigue on 6-28-20 (I had cut grass that day it was hot-blamed on that).  On 6-29-20 I was extremely tired. Slept after work.  Very tired again on 6-30-20 but now  barely able to eat or drink anything.  Slept after work until  approx. 7:30 pm and woke up with a 102.4 fever.   Taken to ER because the pharmacy and the Urgent care were closed.
Pt developed jaw pain 3 days post vaccine. 5 days post vaccine pt became lethargic, photophobic, developed a headache with position changes, had a low grade fever with chills followed by night sweats. Appetite was diminished.  Pt still suffering stiff neck 11 days post vaccine.
panic attacks; believe that vaccine has negatively effected my hormones; have had a huge increase in migraines; unusually intense period symptoms; carpel tunnel in my hands and wrists; This is a spontaneous report from a contactable consumer or other health professional (patient) of 35-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) dose 1 via an unspecified route of administration, administered in Arm Left on 12Mar2021 17:00pm (at the age of 35 years old) (Batch/Lot number was not reported) as dose 1, single and dose 2 via an unspecified route of administration, administered in Arm Left on 09Apr2021 15:45 pm (Batch/Lot Number: EW0162) as dose 2, single both for covid-19 immunization at Pharmacy or Drug Store. The patient's medical history included covid-19 from unknown date and unknown if ongoing and concomitant medications were not reported. No known allergies. No allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient reported that on 01Apr2021, she believed that vaccine had negatively affected her hormones. The patient had a huge increase in migraines, unusually intense period symptoms, carpel tunnel in her hands and wrists, and panic attacks. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient receive treatment for the adverse events. and Prescription for migraines. The clinical outcome of the events was not recovered.  Information about lot/batch number is available. Follow-up attempts are needed.
14-year-old patient received Infanrix on 26May2022; Intending to administered a Tdap and Infanrix was given in error to this patient.; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 14-year-old male patient who received DTPa (Infanrix) (batch number 7EC55, expiry date 29th April 2023) for prophylaxis.   Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 24th May 2022, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 24th May 2022, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 26-MAY-2022 Reporter's Comments: The reporter was a medical assistant. The reporter reported that a 14-year-old patient received Infanrix. They were intending to administer a Tdap and Infanrix was given in error to this patient. The reporter consented to follow up. Additional Supportive Information: A 14-year-old patient received Infanrix vaccine instead of Tdap, which led to inappropriate age at vaccine administration and wrong vaccine administered.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 21-SEP-2015, the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (dose, frequency, route of administration, lot # and expiration date were not reported). There was no adverse effect reported. Additional information is not expected as there was no consent for follow up.
Headache, Myalgia, NauseaVomiting, site pain; nausea after meals; chills, body aches, dry heaves Narrative:
began w/laryngitis, chills & fever, diarrhea until 5OCT95, joint pains;
after injection pt felt dizzy, brought to Observation 1 in wheelchair.  Given apple juice and crackers at 09:28.  Vitals at 09:20 a.m. BP 124/73, pulse 86,resp. 16, O2 96%.  Pt. lying down. Vitals at 09:38 am, bp 111/64, pulse 68, resp.18, O2 98. Pt reports feeling better , gait steady, discharged in wheelchair at 09:42 a.m.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. No information on the patients' concomitant medications, concurrent conditions, pertinent medical history, drug reactions or allergies was reported. On unknown dates between 07-JUN-2016 and 08-DEC-2016, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot # L043213 with expiry date on 28-AUG-2017, lot # L019297 with expiry date on 18-AUG-2017 and lot # L020015 with expiry date on 16-AUG-2017; dose and route of administration were not reported) for prophylaxis. On 07-JUN-2016, doses of GARDASIL 9 underwent a temperature excursion of minimum 25 degrees Fahrenheit for 12 hours prior to being administered. There were no known adverse effects. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA010752: US-009507513-1612USA010753: US-009507513-1612USA010751.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' pertinent medical histories, concomitant medications and drug reactions or allergies reported. On an unknown dates, the patients were vaccinated with an improperly stored doses of RECOMBIVAX HB (lot# M001578, expiration date 21-NOV-2018, dose, anatomical location and route of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Tachycardia, chest tightness and difficulty breathing which lasted for a day. She then had once episode of tachycardia on Saturday and one on Sunday. She had to go to the ER where they discovered that her liver enzymes were also elevated. Her PMD was able to palpate her liver on Saturday 11/13/21. She saw a Cardiologist on 11/16/21 and a GI doctor on 11/18/21. She had repeat blood tests today, the results are pending and has to follow up with GI on 12/9/21.
"Covid Arm" : rash originating around site of vaccine and traveling along arm to elbow. This started 9 days after receiving vaccine. took 2 Benadryl over the course of 2 days. dizziness today.
Started with chills.  Then fever and nausea, then body aches.  Symptoms lasted 48 hours.  Fever ranged from 101.9 to 99.3 for two days.  Treated with ibuprofen.
This spontaneous report was received from a Licensed Practical Nurse refers to multiple unspecified patients of an unknown age. The patient's pertinent medical history and concomitant medications were not reported. On unspecified dates, multiple unspecified patients were vaccinated with improperly stored (at 30 F for cumulative total of 10 hours and 30 minutes) VARIVAX (Merck) (lot # L027787; expiry date: 21-JUL-2017). No adverse effect reported. Additional information has been requested.
Received the vaccine Wednesday afternoon and by Saturday afternoon I broke out in hives.  My back is covered with them.  I had a few on my face and legs.  The upper part of my legs and chest had moderately infections.
This spontaneous report as received from a physician via company representative, and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 10-MAR-2014, the patient was vaccinated with a dose of improperly stored PNEUMOVAX 23 and lot number J009689 with expiration date of 29-JAN-2015 (route of administration was unknown), which was stored at 34 Fahrenheit (F) Degrees (1.111111111 Celsius) for a total of 144 hours. The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effect were reported nor product quality complaint was involved. This is one of several cases received from the same reporter. Additional information has been requested.
Post vax, on 10/21/99, the pt experienced a raised, red and tender area at the injection site, flu-like symptoms, achiness, fever and sluggishness. No treatment was given. The most recent information, received on 11/3/99, reports the symptoms resolved.
I felt my throat closing up, making it more and more difficult to swallow or breathe; my throat felt like a mild cold; more difficult to swallow; difficult to swallow or breathe; hives on my neck; swollen face and neck; swollen face and neck; This is a spontaneous report from a contactable consumer (patient).   A 52-years-old female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Left on 18Mar2021 12:00 (Batch/Lot Number: EN 620H) as single dose for covid-19 immunisation.  Medical history included high blood pressure from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  No other vaccine in four weeks. The patient previously took polio vaccine for immunization and experienced allergy, nickel and experienced allergy, chloroxylenol and experienced allergy, cetirizine hydrochloride (ZYRTEC) and experienced allergy, clarithromycin (CLARITIN) and experienced swelling face. The patient stated that, "After the vaccine was administered (18Mar2021 12:00) my throat felt like a mild cold making it a little more difficult to swallow. As I was sent to the high risk area I was monitored by a nurse. Upon leaving I got into my car that was warm inside. As I was driving I felt my throat closing up, making it more and more difficult to swallow or breathe. I went to a (store) and spoke to the pharmacist there. She advised me to take Benadryl immediately. She noticed hives on my neck and a swollen face and neck. As Benadryl took effect the hives receaded and the swelling of my face and neck went down. I went back to the vaccination site and seemed medical attention from the (Department name) Department team. They checked my vital signs and released me after a waiting period without any further medication being administered. I was given an appointment for 08Apr2021. I am concerned about an adverse reaction at the second appointment. Is it better to wait a little longer for the second dose to be given?" Patient is not pregnant.  Therapeutic measures were taken as a result of the events included Benadryl. Outcome of the events was resolving.
experienced 3 days of coughing; This is a spontaneous report from a contactable consumer reporting for her friend.  A 53-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced 3 days of coughing after the first dose on an unspecified date with outcome of unknown. Information about Lot/Batch number is requested.
Patient presented to the hospital on 5/25/21 with left dysarthria, left arm and leg weakness that presented acutely.  Patient has a pre-existing left facial weakness from previous Bell's palsy.  Patient did not have any falls.
Information has been received from a physician concerning a 14 year old female who on 01-MAY-2008 was vaccinated with the first dose of GARDASIL.  On 02-AUG-2008 was vaccinated with second dose of GARDASIL (lot no. 660389/1968U) (site and route not reported).  Concomitant therapy included hormonal contraceptives (unspecified).  Physician reported that the patient experienced arthritic pain in her hand and back after second dose of GARDASIL.  Physician reported that the patient saw another physician on 26-JAN-2009 for the pain.  Additional information has been requested.
Blisters on her fingers and on the palm of her hand; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (Blisters on her fingers and on the palm of her hand) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025M208A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced BLISTER (Blisters on her fingers and on the palm of her hand). At the time of the report, BLISTER (Blisters on her fingers and on the palm of her hand) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   No treatment information were reported.   Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Child brought to clinic to receive his kindergarten immunizations. Instead of receiving his fifth dose of DTaP he received TdaP, which is for children over 11 years of age. No adverse reaction seen at the time of immunization and nothing occurred or was reported to the clinic. Attempted to contact mother on 06/27/08 for status of child but the number mom provided was wrong.
Pt has had an SUT her entire life. She has had 2 episodes in the last 3 weeks that sent her to the ER. On of those episodes occurred after her vaccination. (SVT = Ventricle tachycardia).